CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expression

Modern Pathology

Volumn 28, Issue 1, 2015, Pages 57-68

  Smith, Steven Christopher ^a,b   Buehler, Darya ^c,e   Choi, Eun Young Karen ^a   McHugh, Jonathan B ^a   Rubin, Brian P ^d   Billings, Steven D ^d   Balzer, Bonnie ^b   Thomas, Dafydd G ^a   Lucas, David R ^a   Goldblum, John R ^d   Patel, Rajiv M ^a,e  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c University of Wisconsin Health   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TRANSCRIPTION FACTOR ETS; CIC PROTEIN, HUMAN; DUX4 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; EWING SARCOMA; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; ONCOGENE MYC; PROTEIN EXPRESSION; SARCOMA; TRISOMY 8; BIOSYNTHESIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; PATHOLOGY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SMALL CELL SARCOMA; SOFT TISSUE TUMOR; YOUNG ADULT;

ADULT; FEMALE; GENE AMPLIFICATION; GENES, MYC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES; SARCOMA, SMALL CELL; SOFT TISSUE NEOPLASMS; YOUNG ADULT;

EID: 84920685825     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2014.83     Document Type: Article

References (37)

1. Pawel BR, Hamoudi AB, Asmar L, et al. Undifferentiated sarcomas of children: pathology and clinical behavior-an Intergroup Rhabdomyosarcoma study. Med Pediatr Oncol 1997;29:170-180.
2. Graham C, Chilton-MacNeill S, Zielenska M, et al. The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas. Hum Pathol 2012;43:180-189.
3. Machado I, Cruz J, Lavernia J, et al. Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasis. Virchows Arch 2013;463:837-842.
4. Rakheja D, Goldman S, Wilson KS, et al. Translocation (4;19)(q35;q13.1)-associated primitive round cell sarcoma: report of a case and review of the literature. Pediatr Dev Pathol 2008;11:239-244.
5. Yoshimoto M, Graham C, Chilton-MacNeill S, et al. Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event. Cancer Genet Cytogenet 2009;195:1-11.
6. Italiano A, Sung YS, Zhang L, et al. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer 2012;51:207-218.
7. Kajtar B, Tornoczky T, Kalman E, et al. CD99-positive undifferentiated round cell sarcoma diagnosed on fine needle aspiration cytology, later found to harbour a CIC-DUX4 translocation: a recently described entity. Cytopathology 2013;25:129-132.
8. Kawamura-Saito M, Yamazaki Y, Kaneko K, et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 2006;15:2125-2137.
9. Richkind KE, Romansky SG, Finklestein JZ. t(4;19)(q35;q13.1): a recurrent change in primitive mesenchymal tumors? Cancer Genet Cytogenet 1996; 87:71-74.
10. Somers GR, Shago M, Zielenska M, et al. Primary subcutaneous primitive neuroectodermal tumor with aggressive behavior and an unusual karyotype: case report. Pediatr Dev Pathol 2004;7:538-545.
11. Choi EY, Thomas DG, McHugh JB, et al. Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology. Am J Surg Pathol 2013;37:1379-1386.
12. Antonescu C. Round cell sarcomas beyond Ewing: emerging entities. Histopathology 2014;64:26-37.
13. Tomlins SA, Palanisamy N, Brenner JC, et al. Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors. Am J Clin Pathol 2013;139:771-779.
14. Bhalla R, Kunju LP, Tomlins SA, et al. Novel dualcolor immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma. Mod Pathol 2013;26:835-848.
15. Young A, Palanisamy N, Siddiqui J, et al. Correlation of urine TMPRSS2:ERG and PCA3 to ERG\+ and total prostate cancer burden. Am J Clin Pathol 2012;138:685-696.
16. Collins LC, Botero ML, Schnitt SJ. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol 2005;123:16-20.
17. Hu G, Wei Y, Kang Y. The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res 2009;15: 5615-5620.
18. Coller HA, Grandori C, Tamayo P, et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci USA 2000;97:3260-3265.
19. Fletcher CDM. World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of soft tissue and bone, 4th edn. IARC Press: Lyon, 2013.
20. von Mehren M, Benjamin RS, Bui MM, et al. Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2012;10: 951-960.
21. Krane JF, Bertoni F, Fletcher CD. Myxoid synovial sarcoma: an underappreciated morphologic subset. Mod Pathol 1999;12:456-462.
22. Folpe AL, Hill CE, Parham DM, et al. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 2000;24:1657-1662.
23. Brenner JC, Feng FY, Han S, et al. PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma. Cancer Res 2012;72:1608-1613.
24. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-648.
25. Miettinen M, Wang ZF, Paetau A, et al. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol 2011;35:432-441.
26. Wang WL, Patel NR, Caragea M, et al. Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma. Mod Pathol 2012;25: 1378-1383.
27. Specht K, Sung YS, Richter G, et al. A Comparative Immunohistochemical and Molecular Study of CIC-DUX4-Fusion Positive Round Cell Sarcomas Versus EWSR1-Rearranged Ewing Sarcomas-Further Evidence toward Distinct Pathologic Entities. Mod Pathol 2014;27:11-33; A105.
28. Smith SC, Palanisamy N, Choi EK, et al. Overexpression of ETS-Family Transcription Factors in CIC-DUX4 Sarcomas: A Useful Diagnostic Adjunct? Mod Pathol 2014;27:11-33; A103.
29. Dang CV. MYC on the path to cancer. Cell 2012;149: 22-35.
30. Dauphinot L, De Oliveira C, Melot T, et al. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene 2001;20:3258-3265.
31. Deming SL, Nass SJ, Dickson RB, et al. C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer 2000;83:1688-1695.
32. Hoffman B, Amanullah A, Shafarenko M, et al. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 2002;21:3414-3421.
33. Sollazzo MR, Benassi MS, Magagnoli G, et al. Increased c-myc oncogene expression in Ewing's sarcoma: correlation with Ki67 proliferation index. Tumori 1999;85:167-173.
34. Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004;5:365-374.
35. Milhem MM, Knutson T, Yang S, et al. Correlation of MTDH/AEG-1 and HOTAIR Expression with Metastasis and Response to Treatment in Sarcoma Patients. J Cancer Sci Ther 2011;Suppl 5:004.
36. Wang F, Ke ZF, Sun SJ, et al. Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis. Cancer Biol Ther 2011;12:539-548.
37. Orentas RJ, Yang JJ, Wen X, et al. Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers. Front Oncol 2012;2:194.